Loading...

Replimune Group, Inc.

REPL•NASDAQ
Healthcare
Biotechnology
$3.10
$-0.23(-7.05%)

Replimune Group, Inc. (REPL) Stock Chart & Performance Analysis

Explore Replimune Group, Inc.’s stock chart, historical data, and performance trends for a deeper market understanding.

1-Day Change
-5.34%
5-Day Change
-10.13%
1-Month Change
-37.88%
3-Month Change
-37.43%
6-Month Change
-37.77%
Year-to-Date (YTD) Change
-44.90%
1-Year Change
-0.57%
3-Year Change
-61.19%
5-Year Change
-37.03%
All-Time (Max) Change
-54.35%

Analyzing Replimune Group, Inc. (REPL) Trends Across Multiple Time Frames

Replimune Group, Inc. Charts reveal critical insights by breaking down performance into different periods from short-term swings to long-term trends. Replimune Group, Inc. stock shows -5.34% 1-day change, indicating low volatility, while its 5-day change of -10.13% suggests a broader trend. Over a 1-month period, a -37.88% drop could signal a pullback, whereas a 3-month decline of -37.43% may reflect broader market sentiment. Longer timeframes help assess sustained performance. A 6-month change of -37.77% and a YTD drop of -44.90% might concern investors, but a 1-year loss of -0.57% and a 3-year drop of -61.19% could indicate resilience. The 5-year surge of -37.03% highlights weak historical growth, while the all-time return of -54.35% underscores long-term potential. Whether tracking intraday moves or multi-year trends, analyzing these metrics helps traders and investors make data-driven decisions.

Frequently Asked Questions

;